Period |
Institute |
Where |
Topic |
| 24-27 April, 2012 |
Southern Sweden Cancer Center |
Lund, Sweden |
Translational Oncology - from bioinformatics to clinical informatics; focus on hereditary, breast cancer, melanoma and sarcoma |
| 6-9 February, 2012 |
Institute Gustave Roussy |
Villejuif, France |
Integration of molecular medicine into clinical trials. The report will be available after the visit |
| 12-14 October, 2011 |
The European Institute of Oncology |
Milan, Italy |
Circulating endothelial cells and progenitors as biomarkers in anti-angiogenic therapy of cancer |
| 10-13 October, 2011 |
Oncology Institute of Southern Switzerland (IOSI) |
Bellinzona, Switzerland |
Translational studies and new drug development in Oncology: The importance of the laboratory-clinical interface. |
| 27-29 April, 2011 |
Vall d'Hebron |
Barcelona, Spain |
An introduction to Translational Research in Oncology |
| November 2-4, 2010 |
Radboud University Nijmegen Medical Center |
Nijmegen, The Netherlands |
New avenues in Translational Research:
|
| 27th to 29th October, 2010 |
The Molekulare Krebsforschungszentrum of the Charité |
Berlin, Germany |
Translational cancer research: the laboratory-clinical interface at the MKFZ |
29 March to 1 April 2010 |
University Medical Center Groningen (UMCG) |
Groningen, The Netherlands |
Translational Research illustrated through the following themes: Molecular imaging, Long term toxicity and early (pre)clinical trials, Microenvironment, infiltration and metastasis of tumor cells and several aspects of gynaecological oncology trials |
| 27-30 October, 2009 |
Institute Curie |
Paris, France |
Translational Research in Breast Cancer
Including: Tumor profiling, circulating tumor cells and disseminated tumor cells: detection, prognostic value, potential marker to monitor the efficacy of treatment, clinical grafts: a tool for defining new drugs association and new targets, epigenetic in Breast cancers, hereditary breast cancers |
| 23-25 March, 2009 |
Jules Bordet Institute |
Brussels, Belgium |
Integrating tumor profiling, tumor microenvironment and minimal residual disease to predict clinical outcome and response to various therapeutics in breast cancer patients. |
| 6-9 October, 2008 |
Instituto Nazionale Tumori |
Milan, Italy |
Soft tissue sarcomas, GIST and melanoma. |
| 21-24 April, 2008 |
I.O.S.I. |
Bellinzona, Switzerland |
Translational studies and new drug development in Oncology: the laboratory-clinical interface. |
| 16-19 April, 2007 |
Norwegian Radium Hospital |
Oslo, Norway |
New avenues in molecular diagnostics, immunotherapy, micro-metastases and tumor stem cells. |
| 14-16 February, 2007 |
Vall d'Hebron Hospital |
Barcelona, Spain |
Early Clinical Development of Molecular Targeted Therapies. |
| 23-26 March, 2006 |
Institut Gustave Roussy |
Villejuif, France |
How to succeed in translational research. |
| 21-24 February 2006 |
Cancer Centre Karolinska |
Stockholm, Sweden |
Tumor immunology and immunotherapy. |
| 13-15 April, 2005 |
Vall d'Hebron Hospital |
Barcelona, Spain |
Early Clinical Development of Molecular Targeted Therapies. |
| 23-25 February, 2005 |
Radcliffe Infirmary |
Oxford, UK |
Gene Therapy for Cancer. |
| 21-23 April, 2004 |
Karolinska Institute |
Stockholm, Sweden |
Tumor immunology and immunotherapy. |